Wordt geladen...
Potential prostate cancer drug target: Bioactivation of androstanediol by conversion to dihydrotestosterone
High affinity binding of dihydrotestosterone (DHT) to the androgen receptor (AR) initiates androgen-dependent gene activation required for normal male sex development in utero, and contributes to prostate cancer development and progression in men. Under normal physiological conditions, DHT is synthe...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3177006/ https://ncbi.nlm.nih.gov/pubmed/21705451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-0644 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|